PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
23-Jan-2020 BHF announces shortlist for £30m research prize at start of defining decade for CVD The British Heart Foundation
23-Jan-2020 Risdiplam (RG7916) Pivotal FIREFISH Study Demonstrated Statistically Significant Improvement in Infants with Type 1 Spinal Muscular Atrophy PTC Therapeutics,Inc
22-Jan-2020 Contract research firm set to double in size following Northern VCT investment Gentronix Ltd
22-Jan-2020 Freeline to present further FLT180a data at EAHAD Freeline
22-Jan-2020 Biotech start-up Seekyo raises €800k with leverage from French Tech Seed Fund Seekyo
22-Jan-2020 Myeloma UK London Paris Ride 2020 Launch Myeloma UK
22-Jan-2020 Hansa Biopharma to host conference call to provide Year-End report 2019 and Business Update Hansa Biopharma
22-Jan-2020 Alliance Pharma PLC - Full Year Trading Update Alliance Pharma plc
22-Jan-2020 TISSIUM Recognized as a French Tech 120 Company TISSIUM
22-Jan-2020 Toxys Strengthens Leadership Team with Appointment of CBO and COO Positions Toxys
22-Jan-2020 Abeona Therapeutics Announces Participation in Inaugural World Congress on Epidermolysis Bullosa Abeona Therapeutics
22-Jan-2020 Novartis receives European licence for Mayzent®▼(siponimod), the first oral treatment for secondary progressive multiple sclerosis (SPMS) with active disease Novartis
22-Jan-2020 Polaryx Therapeutics Receives IND Approval for PLX-200 From the FDA for the Treatment of Late Infantile Neuronal Ceroid Lipofuscinosis Polaryx Therapeutics, Inc
22-Jan-2020 PredictImmune announces commercial partnership with Cambridge Clinical Laboratories (CCL) to promote and supply PredictSURE IBD™, the world’s first validated prognostic test for inflammatory bowel disease PredictImmune
22-Jan-2020 Bioprocessing Summit Europe Returns March 24-26, 2020 in Barcelona with New Analytical and Formulation Sessions Cambridge Healthtech Institute
22-Jan-2020 European Commission Approves Darzalex®▼ (daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone (VTd) for Patients with Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible The Janssen Pharmaceutical Companies of Johnson & Johnson
22-Jan-2020 Genmab Announces European Marketing Authorization for DARZALEX® (Daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma Genmab
22-Jan-2020 HepaRegeniX GmbH Secures Series B Financing in Excess of €11 Mio. to Advance First Drug Candidate to the Clinic HepaRegeniX GmbH
22-Jan-2020 7MM to see sepsis cases grow to 3.1 million by 2026, says GlobalData GlobalData
22-Jan-2020 IQVIA Named to FORTUNE’s 2020 List of “World’s Most Admired Companies” IQVIA